Zurich Insurance Group (ZURN) H1 2019 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2019 earnings summary
17 Nov, 2026Executive summary
Best first-half results in a decade; BOP rose 16% to $2.815bn and net income attributable to shareholders increased 14% to $2.041bn.
Annualized BOPAT ROE was 15.0%; estimated Z-ECM capital ratio was 121%, above the 100%–120% target range.
P&C underwriting improvement and strong investment performance drove results; management said it was on track to exceed its 2017–2019 strategic targets.
Financial highlights
Total revenues were $39.198bn vs. $27.764bn; the comparison included $13.875bn of unit-linked investment result vs. $1.753bn in H1 2018.
Net income attributable to shareholders rose 14% to $2.041bn; basic EPS was $13.81 vs. $12.05.
Net income before tax was $3.132bn vs. $2.646bn; the effective tax rate on shareholder income fell to 24.9% from 26.8%.
Net investment result on Group investments increased 14% to $3.564bn, including $907m of net capital gains vs. $398m.
Outlook and guidance
2017–2019 targets were on track to be exceeded: cumulative cash remittances reached $9.2bn through June, toward a $9.5bn target; net cost savings were $1.3bn, toward $1.5bn.
Management expected the remaining cost savings to be delivered in H2 2019 and planned to announce new three-year strategic targets at the November 14 Investor Day.
BOPAT ROE of 15.0% exceeded the 2017–2019 target of more than 12%; Z-ECM was 121% against a 100%–120% target range.
Latest events from Zurich Insurance Group
- Beazley scales Specialty as targets, synergies and AI productivity advance.ZURN
Investor Day 2026 - Higher earnings and BOP, despite a sharp swing in unit-linked investment results.ZURN
H2 2018 - COVID-19 and volatile markets cut H1 earnings, while commercial growth and capital resilience held firm.ZURN
H1 2020 - BOP rose 16%, all three-year targets were exceeded, and a CHF 20 dividend was proposed.ZURN
H2 2019 - BOP rose 60%, while P&C’s 93.9% combined ratio marked a 20-year-plus low.ZURN
H1 2021 - COVID-19 and catastrophe losses cut BOP 20%, while commercial pricing strengthened.ZURN
H2 2020 - Record 2021 profits, stronger underwriting and 212% SST support the 2022 outlook.ZURN
H2 2021 - Higher BOP was offset by investment-market losses and an $8.8bn IFRS 17 opening-equity reduction.ZURN
H2 2022 - Record BOP and 23.1% BOPAT ROE supported higher shareholder returns.ZURN
H2 2023